Covaxin likely to get WHO's approval by the end of Sept: Sources 

India Today 2021-09-13

Views 1.3K

Bharat Biotech's Covaxin is likely to get World Health Organisation's (WHO) approval by the end of this month, according to sources.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources
play
01:51

Bharat Biotech's Covaxin gets SEC approval for emergency use_ Sources
Reshuffle of Gujarat cabinet ministry is likely to be on 17th Sept- Sources
play
01:14

Reshuffle of Gujarat cabinet ministry is likely to be on 17th Sept- Sources
Trump likely to visit India at the end of February, say sources
play
00:53

Trump likely to visit India at the end of February, say sources
Delhi assembly elections likely in January end - February next year: Sources
play
02:25

Delhi assembly elections likely in January end - February next year: Sources
'Covaxin Will Most Likely Get Intl Approval By Aug' Dr Manish Singhal, Apollo Hospital On NewsX
play
12:47

'Covaxin Will Most Likely Get Intl Approval By Aug' Dr Manish Singhal, Apollo Hospital On NewsX
WHO says decision on emergency approval for Covaxin likely in 4 to 6 weeks
play
01:46

WHO says decision on emergency approval for Covaxin likely in 4 to 6 weeks
Delhi's air quality deteriorates to 'very poor' category; Covaxin gets WHO's approval for emergency use; more
play
54:59

Delhi's air quality deteriorates to 'very poor' category; Covaxin gets WHO's approval for emergency use; more
Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News
play
01:49

Bharat Biotech’s Covid-19 vaccine Covaxin gets WHO’s emergency use approval | Oneindia News
Why Does Bharat Biotech's Covaxin Need WHO's Approval?
play
02:57

Why Does Bharat Biotech's Covaxin Need WHO's Approval?
Bharat Biotech’s Covaxin To Get WHO’s Approval Soon, Says IFS Harsh Vardhan Singla
play
01:59

Bharat Biotech’s Covaxin To Get WHO’s Approval Soon, Says IFS Harsh Vardhan Singla
Centre has sought 45 lakh more doses of Covaxin, say sources
play
00:53

Centre has sought 45 lakh more doses of Covaxin, say sources
Bharat's Biotech Covaxin recommended for phase 2 and 3 trials on 2 to 18 year-olds_ Sources _ TV9
play
00:33

Bharat's Biotech Covaxin recommended for phase 2 and 3 trials on 2 to 18 year-olds_ Sources _ TV9